Merck KGaA, Thermo Fisher Scientific Inc. and Cytiva (a subsidiary of Danaher) are Dominating the Global Viral Vector Purification Market in 2020

Global Viral Vector Purification Market is expected to grow with the CAGR of 14.2% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below:

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-viral-vector-purification-market

Global viral vector purification market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in global viral vector purification market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio For instance:

  • In 2020, Thermo Fisher Scientific to Double its Capacity of Viral Vector Manufacturing and development services with building of a new commercial site of manufacturing in Plainville, Mass. The ~$180 million project will be more than dual the company's commercial viral vector capability to support growing demand for the development and manufacture of gene therapies and vaccines.

Thermo Fisher Scientific Inc. is the dominating player in global viral vector purification market. The other key players existing in the market are Applied Biological Materials Inc., Creative Biolabs, Bio-Rad Laboratories, Inc., Sirion-Biotech GmbH, Merck KGaA, FUJIFILM Diosynth Biotechnologies, Batavia Biosciences B.V., Agilent Technologies, Inc., Addgene, IDT Biologika GmbH, ProBioGen AG, Takara Bio Inc., Waisman Biomanufacturing, Creative Biogene, Aldevron, uniQure N.V., BioVision Inc., Cytiva (a subsidiary of Danaher) and BIA Separations among others.

Viral Vector Purification MarketThermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. headquartered in Delaware, U.S. Thermo Fisher Scientific Inc., founded in the year 1956. The company is the world leader in serving science, delivering an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services. The company has product categories which are Laboratory Supplies, Laboratory Equipment, Laboratory Instruments , Clinical & Diagnostics, Chromatography & Mass Spectrometry, Cell Culture, Protein & Cell Analysis, Molecular Biology & Nucleic Acid Analysis, Sequence-Specific, Nucleic Acid Products, Chromatography Supplies, ELISA Reagents and Kits among others in which Protein & Cell Analysis, ELISA Reagents and Kits, Chromatography Supplies is the market focused categories.

  • In January 2021, Thermo Fisher Scientific Inc. announced that it has completed the acquisition of Novsep’s viral vector manufacturing business in Belgium which will help the company to further diversify its market.

The company has presence across North America, Asia-Pacific, Europe, Middle East and Africa, South America. The company also has various subsidiary companies such as Thermo Scientific (Massachusetts), Applied Biosystems (California), Invitrogen (California), Fisher Scientific (Massachusetts), Unity Lab Services (Pennsylvania), Patheon (New York) among others.

Cytiva (a subsidiary of Danaher)

Cytiva (a subsidiary of Danaher) headquartered in Massachusetts, U.S. The company is concentrating on biological research to developing innovative vaccines, biologic drugs and novel cell and gene therapies. The company has product categories such as bioprocess filtration, cell culture & fermentation processes, cell therapy technologies, chromatography products, laboratory supplies & accessories, whatman filters, membranes and devices, liquid preparation and management and others in which Chromatography Products is the market focused category.

The company has wide presence across Asia-Pacific, Europe, Americas.

Merck KGaA

Merck KGaA headquartered in Darmstadt, Germany. Merck KGaA is founded in the year 1968. The company is dedicated to solutions and services for research, development and production of biotechnology and pharmaceutical drug therapies. The company has various product categories that are Analytics and Sample Preparation, Biopharmaceutical Manufacturing, Industrial Microbiology, IVD/OEM Materials and Reagents, Life Science Research, Reagents, Chemicals and Labware, Small Molecule Pharmaceuticals, Water Purification in which Biopharmaceutical Manufacturing is the market focused category.

  • In April 2020, Merck KGaA has boosts commercial viral vector and gene therapy manufacturing capacity. This escalation in manufacturing capacity has helped the company for its business and revenue growth.

The company has presence in Asia-Pacific, Europe, Middle East and Africa, Americas. The company also has various subsidiary companies such as Allflex UK Group (U.K.), Dieckmann Arzneimittel GmbH (Germany), Intervet Deutschland GmbH (Germany), Merck Canada Inc. (Canada), Merck Sharp & Dohme Limitada (Bolivia), Immune Design Ltd. (U.K.) and others.